Kazuhisa Nakano Selected Research

Kazuhisa Nakano Research Topics

Disease

27	Rheumatoid Arthritis 10/2023 - 02/2009
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2003
7	Inflammation (Inflammations) 01/2022 - 03/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2024 - 06/2002
4	Neoplasms (Cancer) 10/2023 - 07/2004
4	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 07/2015
4	Fibrosis (Cirrhosis) 01/2022 - 10/2018
4	Immunoglobulin G4-Related Disease 08/2020 - 08/2018
3	Mixed Connective Tissue Disease (MCTD) 11/2022 - 01/2020
3	Pulmonary Arterial Hypertension 11/2022 - 01/2020
3	Dermatomyositis (Dermatopolymyositis) 01/2022 - 10/2018
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 01/2021
3	Infections 01/2022 - 02/2004
3	Vascular Calcification 01/2022 - 05/2015
3	Osteoarthritis 05/2015 - 01/2013
2	Synovitis 09/2022 - 06/2012
2	Spontaneous Remission 01/2022 - 01/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2020
2	Ascites 01/2022 - 01/2021
2	Fever (Fevers) 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 04/2020
2	Pulmonary Hypertension 01/2022 - 01/2020
2	Arthritis (Polyarthritis) 01/2021 - 02/2004
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2004
2	Necrosis 01/2020 - 01/2020
2	Osteoporosis 01/2018 - 05/2015
2	Bone Resorption 05/2015 - 08/2004
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2011 - 08/2008
1	Lung Neoplasms (Lung Cancer) 03/2024
1	Adenocarcinoma 03/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024
1	Lupus Nephritis 10/2022
1	Polymyositis 01/2022
1	Lymphadenopathy 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Disease Progression 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Hepatitis 01/2022
1	Heart Failure 01/2022
1	Glomerulonephritis 01/2022
1	Myelodysplastic-Myeloproliferative Diseases 01/2022
1	Trisomy (Trisomies) 01/2022
1	Hyperuricemia 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Alopecia (Baldness) 01/2022
1	autosomal dominant familial Periodic fever 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022

Drug/Important Bio-Agent (IBA)

7	GlucocorticoidsIBA 01/2022 - 08/2018
6	AntibodiesIBA 11/2022 - 01/2018
6	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 10/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2005
5	Abatacept (Orencia)FDA Link 01/2023 - 07/2016
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 10/2003
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2020
5	Immunoglobulin G (IgG)IBA 01/2022 - 08/2018
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2018
4	InterferonsIBA 04/2021 - 06/2012
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 02/2004
4	Adalimumab (Humira)FDA Link 09/2020 - 09/2013
4	SteroidsIBA 04/2019 - 10/2003
4	SCH 23390IBA 07/2013 - 08/2008
4	Dopamine (Intropin)FDA LinkGeneric 05/2011 - 08/2008
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2010 - 12/2004
3	Antirheumatic Agents (DMARD)IBA 10/2023 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2015
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 03/2011
3	Vasodilator Agents (Vasodilators)IBA 01/2022 - 01/2020
3	Janus Kinase InhibitorsIBA 01/2021 - 06/2012
3	CytokinesIBA 10/2018 - 07/2004
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2019
2	Antinuclear AntibodiesIBA 01/2022 - 10/2003
2	DiureticsIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2019
2	tofacitinibIBA 01/2021 - 06/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 06/2002
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 01/2020
2	CholesterolIBA 01/2019 - 05/2015
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 01/2018
2	tocilizumab (atlizumab)FDA Link 07/2016 - 05/2014
2	Therapeutic UsesIBA 06/2011 - 08/2008
1	Peptides (Polypeptides)IBA 03/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2022
1	5-hydroxymethylcytosineIBA 09/2022
1	DioxygenasesIBA 09/2022
1	Aligeron (AS 2)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	GalactosamineIBA 01/2022
1	Sildenafil Citrate (Viagra)FDA Link 01/2022
1	MineralsIBA 01/2022
1	Cardiolipins (Cardiolipin)IBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	belimumabIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022

Therapy/Procedure

13	Therapeutics 10/2022 - 10/2003
2	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
1	Stem Cell Transplantation 01/2022